Suppr超能文献

育亨宾可增强可乐定对大鼠奋乃静诱导的僵住症的抗僵住症作用。

Yohimbine potentiates the anticataleptic action of clonidine against perphenazine-induced catalepsy in rats.

作者信息

Shukla V K, Garg S K, Kulkarni S K

出版信息

Arch Int Pharmacodyn Ther. 1986 Jul;282(1):44-9.

PMID:3767524
Abstract

The modulatory role of clonidine and yohimbine on the perphenazine-induced catalepsy was studied in rats. Perphenazine (5 mg/kg) produced severe catalepsy which lasted for more than 4 hr. Clonidine (50 micrograms/kg), an alpha 2-agonist, pretreatment offered protection against perphenazine-induced catalepsy. On the other hand yohimbine (5 mg/kg), an alpha 2-antagonist, pretreatment not only showed per se protective action but also potentiated the effects of clonidine against perphenazine-induced catalepsy. Yohimbine also potentiated the protective action of quipazine, a serotonin agonist. The protective effect of yohimbine is explained on the basis of its serotoninergic action.

摘要

研究了可乐定和育亨宾对大鼠奋乃静诱导的僵住症的调节作用。奋乃静(5毫克/千克)可产生持续超过4小时的严重僵住症。α2激动剂可乐定(50微克/千克)预处理可预防奋乃静诱导的僵住症。另一方面,α2拮抗剂育亨宾(5毫克/千克)预处理不仅本身具有保护作用,还增强了可乐定对奋乃静诱导僵住症的作用。育亨宾还增强了5-羟色胺激动剂喹哌嗪的保护作用。育亨宾的保护作用基于其5-羟色胺能作用来解释。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验